التفاصيل البيبلوغرافية
| العنوان: |
A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities. |
| المؤلفون: |
Xie, Guoyou, Wu, Xu-Nian, Ling, Yuyi, Rui, Yalan, Wu, Deyan, Zhou, Jiawang, Li, Jiexin, Lin, Shuibin, Peng, Qin, Li, Zigang, Wang, Hongsheng, Luo, Hai-Bin |
| المصدر: |
Acta Pharmaceutica Sinica B; Feb2022, Vol. 12 Issue 2, p853-866, 14p |
| مصطلحات موضوعية: |
METASTATIC breast cancer, DEMETHYLASE, SUPPRESSORS of cytokine signaling, ADENOSINES, PEROXISOME proliferator-activated receptors |
| مستخلص: |
N 6-methyladenosine (m6A) modification is critical for mRNA splicing, nuclear export, stability and translation. Fat mass and obesity-associated protein (FTO), the first identified m6A demethylase, is critical for cancer progression. Herein, we developed small-molecule inhibitors of FTO by virtual screening, structural optimization, and bioassay. As a result, two FTO inhibitors namely 18077 and 18097 were identified, which can selectively inhibit demethylase activity of FTO. Specifically, 18097 bound to the active site of FTO and then inhibited cell cycle process and migration of cancer cells. In addition, 18097 reprogrammed the epi-transcriptome of breast cancer cells, particularly for genes related to P53 pathway. 18097 increased the abundance of m6A modification of suppressor of cytokine signaling 1 (SOCS1) mRNA, which recruited IGF2BP1 to increase mRNA stability of SOCS1 and subsequently activated the P53 signaling pathway. Further, 18097 suppressed cellular lipogenesis via downregulation of peroxisome proliferator-activated receptor gamma (PPARγ), CCAAT/enhancer-binding protein alpha (C/EBPα), and C/EBPβ. Animal studies confirmed that 18097 can significantly suppress in vivo growth and lung colonization of breast cancer cells. Collectively, we identified that FTO can work as a potential drug target and the small-molecule inhibitor 18097 can serve as a potential agent against breast cancer. 18097, a potent (IC 50 values 0.64 μmol/L) and selective inhibitor of fat mass and obesity-associated protein (FTO), can suppress growth, lipogenesis, and in vivo metastasis of breast cancer cells. [Display omitted] [ABSTRACT FROM AUTHOR] |
|
Copyright of Acta Pharmaceutica Sinica B is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Supplemental Index |
Full Text Finder